Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 38.40
Ask: 38.95
Change: -0.65 (-1.66%)
Spread: 0.55 (1.432%)
Open: 39.00
High: 39.00
Low: 38.40
Prev. Close: 39.25
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

Thu, 04th Mar 2021 11:42

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Futura Medical, up 22% at 20.08 pence, 12-month range 7.16p-24.49p. The pharmaceutical company says it has entered into financing transactions with HT Riverwood Multi-Growth Fund which will provide the company with up to GBP2 million in cash, GBP1.5 million of which has been received.

----------

Franchise Brands, up 7.7% at 109.30p, 12-month range 81p-136.65p. Says it saw a resilient performance through lockdowns and a robust recovery in second half. For 2020, revenue increases by 12% to GBP49.3 million from GBP44.0 million in 2019 and pretax profit increases to GBP3.7 million from GBP3.3 million. Franchise Brands ups final dividend to 0.80p per share from 0.65p paid in 2019.

----------

ThinkSmart, up 6.7% at 77.9p, 12-month range 12p-91.5p. The digital payments business posts rise in interim earnings. For six months to December 31, pretax profit surges to GBP53.7 million from GBP16.0 million after financial instruments gains. ThinkSmart pays 3.4p per share special dividend and capital return in December.

----------

AIM - LOSERS

----------

MediaZest, down 16% at 0.080p, 12-month range 0.01p-0.18p. The audio-visual company says financial results for the eighteen-month period were affected substantially by the Covid-19 pandemic, with reduction in revenue particularly during the first UK lockdown. Revenue GP3.1 million, down from GBP3.3 million year before and swings to GBP478,000 pretax loss from GBP6,000 profit.

----------

Angle, down 9.7% at 79.30p, 12-month range 37.15p-98p. The liquid biopsy company says it has received response from US Food & Drug Administration after requesting clearance for its Parsortix treatment. Says FDA has indicated its review processes for non Covid-19 devices are currently slower than usual due to pandemic priorities. Notes that FDA processes are outside the company's control and it is continuing to expedite all aspects of the process which are under its control in line with previously advised timescales.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 May 2016 08:26

Futura Medical Completes Recruitment For Erectile Dysfunction Study

Read more
15 Mar 2016 10:30

Futura Says Research Costs To Fall After Ramping Up Spending In 2015

Read more
7 Mar 2016 09:08

Futura Medical Appoints Former Glaxo Executive As Non-Executive

Read more
16 Dec 2015 08:27

Futura Medical Achieves Extended Shelf Life For Condom

Read more
24 Nov 2015 11:01

Futura Medical Gets Positive Regulatory Advice On Pain Relief Products

Read more
17 Nov 2015 10:56

Futura Medical Says MED2002 Trial Recruitment Proceeding Well

Read more
23 Oct 2015 06:52

Futura Medical Gets Confirmation Of NHS Reimbursement For MED2002

Read more
14 Oct 2015 08:12

Futura Medical, Quantum Pharma Agree Erectile Dysfunction Drug Deal

Read more
9 Sep 2015 08:29

Futura Medical Loss Widens As It Moves Toward Product Rollouts

Read more
14 Jul 2015 09:01

Futura Medical Says Two Pain Relief Products Meet Endpoints, One Fails

Read more
25 Jun 2015 08:13

Futura Medical Gets All Approvals For MED2002 Efficacy Trial

Read more
17 Jun 2015 11:12

Futura Medical says product portfolio is in line with business plan

Futura Medical, a healthcare company focused on transdermal technology, said on Wednesday its product portfolio has been progressing in line with expectations. Ahead of its annual general meeting, the group said it is working on a modified manufacturing process on its CSD500 condom to extend the pro

Read more
17 Jun 2015 09:16

Futura Medical Says Product Portfolio Progressing In Line With Plans

Read more
17 Jun 2015 07:24

LONDON MORNING BRIEFING: Shares Gain Ahead Of Bank Of England And Fed

Read more
17 Jun 2015 05:23

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.